Hydrochlorothiazide - CAS 58-93-5
Catalog number: 58-93-5
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Hydrochlorothiazide is a diuretic medication often used to treat high blood pressure and swelling due to fluid build up.
Canonical SMILES:
1. Structural and physicochemical aspects of hydrochlorothiazide co-crystals
Jian-Rong Wang, Chanjuan Ye and Xuefeng Mei*. CrystEngComm,2014, 16, 6996–7003
Hydrochlorothiazide (HCT, Scheme 1) is a diuretic drug used for the treatment of hypertension and edemas. It belongs to class IV compounds according to the Biopharmaceutics Classification System (BCS), suffering from both low solubility (0.25 g L−1) and low permeability (log P = −0.07). The low bioavailability of HCT is partially attributed to its poor aqueous solubility. Attempts have been made by several groups to improve the solubility of HCT using various techniques. Captopril is used as a water soluble carrier and the solubility of HCT was enhanced from 0.25 mg mL−1 to 0.62 mg mL−1 when different concentrations of the carrier were applied. An inclusion complex of HCT with β-cyclodextrin had also been synthesized to overcome the solubility limitations. The co-crystallization approach was recently applied to HCT in order to alter its solubility. The synthesis and structure determination of co-crystals of HCT and isonicotinamide were reported by Zaworotko et al. Co-crystals of HCT with nicotinic acid, nicotinamide, succinamide, 4-aminobenzoic acid, resorcin, and pyrogallol have also been reported very recently. The results have shown co-crystallization is a viable approach to improving HCT aqueous solubility.
2. Pharmacological and therapeutic properties of new derivatives of renin inhibitors and endothelin receptor antagonists, and the methods of their determination
Mariusz Stolarczyk,* Anna Apola, Anna Maslanka and Jan Krzek. Anal. Methods,2015, 7, 4419–4442
Combination treatment is preferred in arterial hypertension therapy, and it involves administration of several substances of hypotensive activity. These may be combinations of active substances of various chemical structures and from different pharmacological groups. Therefore, there is a need to elaborate the methods of aliskiren determination in the presence of other substances with hypotensive activity. Such analysis includes inter alia determination of aliskiren in the presence of a diuretic, hydrochlorothiazide. Ezzeldin et al. proposed determination of these substances using HPLC and spectrophotometric methods. In case of the HPLC method, methanol mixtures of the examined substances were separated on an Econosphere C-18 column; the mobile phase was a water–acetonitrile mixture (50 : 50 v/v), the flow rate was 0.5 mL min−1, spectrophotometric detection was at a wavelength of 208nm. The retention time was 2.13 min for aliskiren and 3.79 min for hydrochlorothiazide, the linearity range in turn was 5–150 mgmL−1 for aliskiren and 1–50 mgmL−1 for hydrochlorothiazide.
3. A kinetic spectrofluorometric method, aided by chemometrics, for the analysis of sibutramine,indapamide and hydrochlorothiazide compounds found in weight-reducing tonic samples
Ying Guo, Yongnian Ni,* Jinfeng Chena and Serge Kokot. Anal. Methods,2016, 8,197–204
Sibutramine (Table 1) is an appetite inhibitor, plays a major role in the central nervous system, and influences weight-loss by altering neurotransmitters within the brain. While 5–10% weight losses have been claimed by the consumers of sibutramine, this substance can cause serious side effects, and in general, it is a forbidden additive to the weight-reducing tonics. Currently, it has been withdrawn from the markets in most countries. Indapamide and hydrochlorothiazide are diuretics (Table 1), which are generally used for treating hypertension. Both increase urination, and this promotes dehydration in the recipient. In addition, it is not uncommon to find that both the weight reducing compounds, e.g. sibutramine, and the diuretics, e.g. indapamide and hydrochlorothiazide, have been added to the weight-reducing tonics contrary to drug regulations. They were added so as to produce a tonic that reduces body weight faster. Therefore, simultaneous analysis of these substances in weight-reducing foods is clearly important.
4. Determination of losartan potassium in the presence of hydrochlorothiazide via a combination of magnetic solid phase extraction and fluorometry techniques in urine samples
Amir Farnoudian-Habibi, Sahar Kangari, Bakhshali Massoumi and Mehdi Jaymand*. RSC Adv.,2015, 5,102895–102903
This paper describes a novel, sensitive, and selective method for the determination of losartan potassium (LOS) in the presence of hydrochlorothiazide (HCTZ) in human urine samples. According to the drug loading process (as described in the Experimental section), it was found that HCTZ had an interfering role in this study, due to its low loading on the adsorbent surface, and its lack of exhibition of fluorescence emission. Hence, we optimized all parameters, such as pH values, the amount of adsorbent, the extraction time, the desorption solvent, and the desorption time, for MSPE and the determination of LOS.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products

CAS 52949-83-4 Ajugol

(CAS: 52949-83-4)

Ajugol is an iridiod glucoside isolated from the roots of Rehmannia glutinosa.

CAS 2098836-45-2 AT 1

AT 1
(CAS: 2098836-45-2)

AT 1 has been found to be an analogue of MZ1 and could probably improves the selectivity for the degradation of BRD4.

CAS 3513-03-9 Blasticidin S HCl

Blasticidin S HCl
(CAS: 3513-03-9)

Blasticidin S HCl is a nucleoside antibiotic that is first isolated from Streptomyces griseochromogenes. Blasticidin S inhibits protein synthesis in both prokar...

CAS 42228-92-2 Acivicin

(CAS: 42228-92-2)

Acivicin is a glutamine analog that irreversibly inhibits glutamine-dependent amidotransferases involved in nucleotide and amino acid biosynthesis (Kis = 10 and...

CAS 673202-67-0 Hexa-D-arginine

(CAS: 673202-67-0)

An inhibitor of furin

CAS 4727-31-5 Kartogenin

(CAS: 4727-31-5)

Kartogenin induces the selective differentiation of multipotent mesenchymal stem cells (MSCs) into chondrocytes. Kartogenin binds to filamin A, and disrupts the...

CAS 796073-69-3 DM4

(CAS: 796073-69-3)

DM4, a chemical derivative of maytansine, is an intermediate used to prepare semisynthetic maytansine analogs which can be conjugated with antibodies for the ta...

Avarofloxacin hydrochloride
(CAS: 1001162-01-1)

Avarofloxacin hydrochloride is an antibacterial drug agent.

MK 0434
(CAS: 134067-56-4)

MK 0434 is a Cholestenone 5-alpha reductase inhibitor originated by Merck & Co and it is associated with a significant reduction in dihydrotestosterone. No deve...

BMS 214428
(CAS: 216508-01-9)

BMS 214428 has antineoplastic effect.

CAS 148505-03-7 GRK2i

(CAS: 148505-03-7)

GRK2i is a polypeptide inhibitor of GRK2 that specifically inhibits Gβγ activation of GRK2. GRK2i corresponds to the Gβγ-binding domain and acts as a cellular G...

CAS 405060-95-9 Salubrinal

(CAS: 405060-95-9)

Salubrinal is a selective inhibitor of eIF2α dephosphorylation and inhibits ER stress-mediated apoptosis with EC50 of ~15 μM.

Ingenol disoxate
(CAS: 1383547-60-1)

Ingenol disoxate is a Novel 4-Isoxazolecarboxylate Ester of Ingenol with Improved Properties. Ingenol is a natural product found in the sap of the plant Euphorb...

CAS 64302-87-0 R162

(CAS: 64302-87-0)

R162 is a potent, selectiv inhibitor of glutamate dehydrogenase 1 (GDH1) (Ki = 28.6 µM), with anti-cancer properties. It does not inhibit the activity of other ...

(CAS: 30103-05-0)

DPY-3050 is a useful intermediate for chemical synthesis of a number of biologically active drugs.

CAS 39959-66-5 LY 78335

LY 78335
(CAS: 39959-66-5)

LY 78335 is a phenylethanolamine N-methyl transferase (PNMT) inhibitor.

CAS 119418-04-1 Galanin (1-30) (human)

Galanin (1-30) (human)
(CAS: 119418-04-1)

Galanin (1-30) (human) is a peptide agonist of galanin receptors GalR1 and GalR2. It has an action on intestinal smooth muscle, insulin and somatostatin release...

CAS 253771-21-0 AR-C 102222

AR-C 102222
(CAS: 253771-21-0)

AR-C 102222 has been found to be an iNOS inhibitor and show antinociceptive and anti-inflammatory activity in rodent pain models.

CAS 92236-42-5 Glutapyrone

(CAS: 92236-42-5)

Glutapyrone is a DHP amino acid used in the antiarrhythmic, neuroprotective, stress-protective and radioprotective remedy.

CAS 3440-28-6 Betamipron

(CAS: 3440-28-6)

Betamipron (INN) or N-benzoyl-β-alanine is a chemical compound which is used together with panipenem to inhibit panipenem uptake into the renal tubule and preve...

Chemical Structure

CAS 58-93-5 Hydrochlorothiazide

Quick Inquiry

Verification code

Featured Items